HER2 overexpression a major risk factor for recurrence in pT1a-bN0M0 breast cancer: results from a French regional cohort

The management of pT1a-bN0M0 breast cancer remains an area of controversy. Data from 714 patients classified as having pT1a-bN0M0 breast cancer and treated, from 1999 to 2004 in the Languedoc-Roussillon France, were analyzed. The human epidermal growth factor receptor 2 (HER2) status analyses were c...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouanet, Philippe, Roger, Pascal, Rousseau, Emilie, Thibault, Severine, Romieu, Gilles, Mathieu, Andre, Cretin, Jacques, Barneon, Gilbert, Granier, Mireille, Maran-Gonzalez, Aurelie, Daures, Jean P, Boissiere, Florence, Bibeau, Frederic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930398/
https://www.ncbi.nlm.nih.gov/pubmed/24407937
http://dx.doi.org/10.1002/cam4.167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930398/
https://www.ncbi.nlm.nih.gov/pubmed/24407937
http://dx.doi.org/10.1002/cam4.167

Ejemplares similares